These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8847872

  • 1. Antithrombotic effect of GYKI-14766 in a canine model of arterial and venous rethrombosis: a comparison with heparin.
    Sudo Y, Lucchesi BR.
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):545-55. PubMed ID: 8847872
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibody [7E3 F(ab')2] prevents arterial but not venous rethrombosis.
    Sudo Y, Kilgore KS, Lucchesi BR.
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):241-50. PubMed ID: 7475049
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    Jackson CV, Crowe VG, Frank JD, Wilson HC, Coffman WJ, Utterback BG, Jakubowski JA, Smith GF.
    J Pharmacol Exp Ther; 1992 May; 261(2):546-52. PubMed ID: 1578372
    [Abstract] [Full Text] [Related]

  • 4. Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis.
    Jackson CV, Wilson HC, Growe VG, Shuman RT, Gesellchen PD.
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):587-94. PubMed ID: 7681904
    [Abstract] [Full Text] [Related]

  • 5. Nitroglycerin inhibits experimental thrombosis and reocclusion after thrombolysis.
    Werns SW, Rote WE, Davis JH, Guevara T, Lucchesi BR.
    Am Heart J; 1994 Apr; 127(4 Pt 1):727-37. PubMed ID: 8154409
    [Abstract] [Full Text] [Related]

  • 6. TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog.
    Rebello SS, Driscoll EM, Lucchesi BR.
    Stroke; 1997 Sep; 28(9):1789-96. PubMed ID: 9303027
    [Abstract] [Full Text] [Related]

  • 7. CVS-1123, a direct thrombin inhibitor, prevents occlusive arterial and venous thrombosis in a canine model of vascular injury.
    Rebello SS, Miller BV, Basler GC, Lucchesi BR.
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):240-9. PubMed ID: 9057074
    [Abstract] [Full Text] [Related]

  • 8. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 9. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA, Steinbacher TE, Heran CL, Seiler SM, Michel IM, Ogletree ML.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
    [Abstract] [Full Text] [Related]

  • 10. Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.
    Hennan JK, Hong TT, Shergill AK, Driscoll EM, Cardin AD, Lucchesi BR.
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1151-6. PubMed ID: 12023550
    [Abstract] [Full Text] [Related]

  • 11. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR, Lynch JJ, Sitko GR, Mellott MJ, Holahan MA, Stabilito II, Stranieri MT, Zhang G, Lynch RJ, Manno PD.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [Abstract] [Full Text] [Related]

  • 12. The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis.
    McClanahan TB, Hicks GW, Morrison AL, Peng YW, Janiczek-Dolphin N, Mertz TE, Sullivan ME, Morser J, Juneau PL, Leadley R.
    Eur J Pharmacol; 2001 Dec 07; 432(2-3):187-94. PubMed ID: 11740955
    [Abstract] [Full Text] [Related]

  • 13. Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery.
    Rote WE, Werns SW, Davis JH, Feigen LP, Kilgore KS, Lucchesi BR.
    Cardiovasc Res; 1993 Mar 07; 27(3):500-7. PubMed ID: 8490951
    [Abstract] [Full Text] [Related]

  • 14. Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.
    Hong TT, Van Gorp CL, Cardin AD, Lucchesi BR.
    Thromb Res; 2006 Mar 07; 117(3):333-42. PubMed ID: 15893368
    [Abstract] [Full Text] [Related]

  • 15. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U, Ku P, Malinowski J, Zhu BY, Scarborough RM, Marlowe CK, Wong PW, Lin PH, Hollenbach SJ.
    Eur J Pharmacol; 2000 Apr 21; 395(1):51-9. PubMed ID: 10781674
    [Abstract] [Full Text] [Related]

  • 16. Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis.
    Markland FS, Friedrichs GS, Pewitt SR, Lucchesi BR.
    Circulation; 1994 Nov 21; 90(5):2448-56. PubMed ID: 7955202
    [Abstract] [Full Text] [Related]

  • 17. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K, Kloner RA.
    Cardiovasc Res; 1993 Jun 21; 27(6):925-34. PubMed ID: 8221780
    [Abstract] [Full Text] [Related]

  • 18. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B, Fareed J.
    Thromb Haemost; 1996 Oct 21; 76(4):615-20. PubMed ID: 8903005
    [Abstract] [Full Text] [Related]

  • 19. The antithrombotic effects of CI-1028, an orally bioavailable direct thrombin inhibitor, in a canine model of venous and arterial thrombosis.
    McClanahan TB, Hicks GW, Ignasiak DP, Bousley R, Mertz TE, Juneau P, Janiczek-Dolphin N, Kim IC, Gallagher KP.
    J Thromb Thrombolysis; 2000 Dec 21; 10(3):277-84. PubMed ID: 11122549
    [Abstract] [Full Text] [Related]

  • 20. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
    Duval N, Lunven C, O'Brien DP, Grosset A, O'Connor SE, Berry CN.
    Br J Pharmacol; 1996 Jun 21; 118(3):727-33. PubMed ID: 8762100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.